Research Article
Correlation between LSM1 Expression and Clinical Outcomes in Glioblastoma and Functional Mechanisms
Table 2
Survival analysis of glioma patients.
| Characteristics | Cases () | Univariate analysis | Multivariate analysis | Hazard ratio (95% CI) | value | Hazard ratio (95% CI) | value |
| Age (years old) | 698 | | <0.001 | | | ≤60 | 555 | Reference | | Reference | | >60 | 143 | 4.696 (3.620-6.093) | <0.001 | 2.054 (1.541-2.737) | <0.001 | Gender | 698 | | 0.071 | | | Female | 297 | Reference | | | | Male | 401 | 1.250 (0.979-1.595) | 0.073 | | | IDH status | 688 | | <0.001 | | | Wild type | 246 | Reference | | Reference | | Mutation | 442 | 0.116 (0.089-0.151) | <0.001 | 0.183 (0.132-0.253) | <0.001 | 1p/19q codeletion | 691 | | <0.001 | | | Noncodel | 520 | Reference | | Reference | | Codel | 171 | 0.225 (0.147-0.346) | <0.001 | 0.634 (0.390-1.028) | 0.065 | LSM1 | 698 | | <0.001 | | | Low | 348 | Reference | | Reference | | High | 350 | 2.878 (2.217-3.735) | <0.001 | 1.473 (1.114-1.949) | 0.007 |
|
|
|